Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kowa Research Institute, Inc.
Age
18–45
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subject provides written informed consent before any study specific evaluation is performed.
Subject is a healthy adult male or female aged 18 to 45 years, inclusive.
Subject has a BMI of 18 to 30 kg/m2, inclusive.
You may not be if
Subject has abnormal findings or assessments that are clinically noteworthy at Screening or Admission (Day -1).
Subject has a supine blood pressure after resting for 5 minutes that is higher than 140 mm Hg systolic or 90 mm Hg diastolic, or lower than 90 mm Hg systolic or 50 mm Hg diastolic at Screening or Admission (Day -1).
Subject has a supine heart rate after resting for 5 minutes that is outside the range of 40 to 100 beats per minute at Screening or Admission (Day -1).
Clareo Health | Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults
